期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心绞痛患者PCI术前大剂量阿托伐他汀对围手术期心肌损伤的影响 被引量：1

Effect of preloading atorvastatin therapy on peri-procedural myocardial infarction among angina pectoris patients undergoing percutaneous coronary intervention
下载PDF
导出
摘要 经皮冠状动脉介入治疗（percutaneous coronary intervention,PCI）是所有采用经皮穿刺方法减轻冠状动脉狭窄的各种心导管技术的总称,早期PCI术主要是指经皮冠状动脉内血管成形术（percutaneous transluminal coronary angioplasty,PTCA）.自从1977年Gruzentig在瑞士完成世界上第一例PTCA后,心血管造影的临床应用日趋广泛,成为临床上判断冠状动脉病变部位和程度的＂金标准＂.
作者 易松
机构地区 宜春市人民医院心血管内科
出处 《中国心血管病研究》 CAS 2014年第1期74-77,共4页 Chinese Journal of Cardiovascular Research
关键词 阿托伐他汀 经皮冠状动脉介入治疗 围手术期 心肌梗死 肌钙蛋白 Atorvastatin Percutaneous coronary intervention Peri-operative period Myocardial infarction Troponin
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献26

  • 1Robertson BJ,Gascho JA,Patti G. Blood glucose level predicts severity of renal and myocardial injury in diabetic patients undergoing coronary interventions[J].Angiography & Interventional Cardiology,2004.1048-1062. 被引量：1
  • 2Frost RJA,Otto C,Geiss HC. Effects of atorvastatin versus fenofibrate on lipoprotein profiles,low-density lipoprotein subfraction distribution,and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia[J].The American Journal of Cardiology,2001.44-48. 被引量：1
  • 3邓昌明,黄晶,刘地川,殷跃辉.血清C-反应蛋白与冠状动脉病变[J].中国心血管病研究,2004,2(1):36-37. 被引量：9
  • 4李呐,刘靖,赵统兵,倪素丹,邱飞英.他汀类药物对冠状动脉血管炎症患者血C-反应蛋白及白细胞介素-6的作用[J].中国心血管病研究,2004,2(6):449-451. 被引量：4
  • 5Patti G,Chello M,Pasceri V. Protection from procedural myocardial Injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention results from the ARMYDA-CAMs(atorvastatin for reduction of myocardial damage during angioplasty-cell adhesion molecules)substudy[J].{H}Journal of the America College of Cardiology,2006.1560-1566. 被引量：1
  • 6Araújo FA,Rocha MA,Mendes JB. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF,TNF-α and TGF-β1[J].{H}BIOMEDICINE & PHARMACOTHERAPY,2010.29-34. 被引量：1
  • 7Di Sciascio G,Patti G,Pasceri V. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention results of the ARMYDA-RECAPTURE(atorvastatin for reduction of myocardial damage during angioplasty)randomized trial[J].{H}Journal of the America College of Cardiology,2009.558-565. 被引量：1
  • 8Veselka J,Hájek P,Maly M. Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins[J].Archives of Medical Science,2011.67-72. 被引量：1
  • 9Turner N,Mughal R,Warburton P. Mechanism of TNFα-induced IL-1α,IL-1β and IL-6 expression in human cardiac fibroblasts:effects of statins and thiazolidinediones[J].{H}Cardiovascular Research,2007.81-90. 被引量：1
  • 10Veselka J,Zemánek D,Hájek P. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention:A single-center,prospective,and randomized study[J].The American Journal of Cardiology,2009.630-633. 被引量：1

二级参考文献21

  • 1[1]Alexander RW. Inflammation and coronary heart disease[J]. N Engl J Med, 1994, 331:468-469 被引量：1
  • 2[2]Paul M Ridker, Mary Cushman, Meir J, et al. Inflammation, Aspirin, and the risk of cardiovascular disease in pparently Healthy man [J]. N Engl J Med, 1997,336: 973-979 被引量：1
  • 3[4]Berk BC, Weintraub WS. Alexander RW. Elevation of C-reactive protein in "active"coronary artery disease[J]. Am J Cardiol, 1990, 65:168-172 被引量：1
  • 4[5]Du clos TW. Function of C-reactive protein[J]. Ann Med, 2000, 32:274-278 被引量：1
  • 5[6]Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiolvascular risk factor: more than an epiphenomenon [J] ? Circulation, 1999, 100: 96-102 被引量：1
  • 6[7]Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor dependent monocyte recruitment in atherogenesis [J]. Artertoscler Thromb Vasc Biol,2000, 20: 2094-2099 被引量：1
  • 7[8]Pasceri V, Willerson JT, Yeh ET, et al. Direct proinflammation effect of C-reactive protein on human endothelial cells[J]. Circulation, 2000, 102: 2165-2168 被引量：1
  • 8[9]Pasceri V, Chang J, Willerson JT, et al. Modulation of C-reactive protein mediated monocyte chemoattracant protien-l induction in human endothelial cells by anti-atherosclerosis drugs[J]. Circulation, 2001, 103:2531-2534 被引量：1
  • 9[10]Nakagomi A, Freedman SB, Geczy CL. Interferon gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protien: relationship with age, sex, and hormone replacement treatment [J]. Circulation, 2000, 101:1785-1791 被引量：1
  • 10[2]Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high - risk individuals: a randomized placebo - controlled trial [ J ]. Lancet, 2002:360: 7 - 22 被引量：1

共引文献11

同被引文献8

引证文献1

中国心血管病研究
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部